These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
574 related articles for article (PubMed ID: 31263988)
1. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer. Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988 [TBL] [Abstract][Full Text] [Related]
2. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
3. Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016. Chen C; Duan H; Zhang W; Zhao H; Wang L; Kang S; Lin L; Zhao W; Ni Y; Li D; Chen J; Fan H; Chen X; Bin X; Lang J; Liu P BMC Cancer; 2021 Oct; 21(1):1091. PubMed ID: 34627169 [TBL] [Abstract][Full Text] [Related]
4. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients. Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230 [TBL] [Abstract][Full Text] [Related]
5. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment. Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539 [TBL] [Abstract][Full Text] [Related]
6. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes. Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination. Altay A; Toptas T; Dogan S; Simsek T; Pestereli E Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255 [TBL] [Abstract][Full Text] [Related]
8. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes. Wang R; Tao X; Wu X; Jiang H; Xia H J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263 [TBL] [Abstract][Full Text] [Related]
9. Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer. Lv X; Chen L; Yu H; Zhang X; Yan D Arch Gynecol Obstet; 2012 Mar; 285(3):811-6. PubMed ID: 21837427 [TBL] [Abstract][Full Text] [Related]
10. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis. Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134 [TBL] [Abstract][Full Text] [Related]
11. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy. Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336 [TBL] [Abstract][Full Text] [Related]
12. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system. Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer. Kubota S; Kobayashi E; Kakuda M; Matsuzaki S; Ueda Y; Yoshino K; Kimura T J Obstet Gynaecol Res; 2019 Mar; 45(3):679-685. PubMed ID: 30565810 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
15. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer? Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616 [TBL] [Abstract][Full Text] [Related]
16. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094 [TBL] [Abstract][Full Text] [Related]
17. [Relationship between metastasis in the para-aortic lymph nodes of cervical cancer and pathological features]. Yu KX; Zhou XR; Wang YQ Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1132-1138. PubMed ID: 36319460 [No Abstract] [Full Text] [Related]
18. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients]. Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease]. Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]